Trials / Conditions / Stage III Urethral Cancer
Stage III Urethral Cancer
5 registered clinical trials studyying Stage III Urethral Cancer.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Afatinib in Advanced Refractory Urothelial Cancer NCT02122172 | University of Chicago | Phase 2 |
| Completed | Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer NCT02437370 | University of California, Davis | Phase 1 |
| Completed | Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointe NCT01846520 | City of Hope Medical Center | N/A |
| Completed | VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium NCT00407485 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transition NCT00072150 | National Cancer Institute (NCI) | Phase 2 |